Literature DB >> 36229903

The Primary Process and Key Concepts of Economic Evaluation in Healthcare.

Younhee Kim1, Yunjung Kim2, Hyeon-Jeong Lee2, Seulki Lee2, Sun-Young Park3, Sung-Hee Oh4, Suhyun Jang5, Taejin Lee6, Jeonghoon Ahn7, Sangjin Shin2.   

Abstract

Economic evaluations in the healthcare are used to assess economic efficiency of pharmaceuticals and medical interventions such as diagnoses and medical procedures. This study introduces the main concepts of economic evaluation across its key steps: planning, outcome and cost calculation, modeling, cost-effectiveness results, uncertainty analysis, and decision-making. When planning an economic evaluation, we determine the study population, intervention, comparators, perspectives, time horizon, discount rates, and type of economic evaluation. In healthcare economic evaluations, outcomes include changes in mortality, the survival rate, life years, and quality-adjusted life years, while costs include medical, non-medical, and productivity costs. Model-based economic evaluations, including decision tree and Markov models, are mainly used to calculate the total costs and total effects. In cost-effectiveness or costutility analyses, cost-effectiveness is evaluated using the incremental cost-effectiveness ratio, which is the additional cost per one additional unit of effectiveness gained by an intervention compared with a comparator. All outcomes have uncertainties owing to limited evidence, diverse methodologies, and unexplained variation. Thus, researchers should review these uncertainties and confirm their robustness. We hope to contribute to the establishment and dissemination of economic evaluation methodologies that reflect Korean clinical and research environment and ultimately improve the rationality of healthcare policies.

Entities:  

Keywords:  Decision trees; Economic evaluation; Incremental cost-effective ratio; Markov model; Medical cost; Quality-adjusted life year

Mesh:

Substances:

Year:  2022        PMID: 36229903      PMCID: PMC9561137          DOI: 10.3961/jpmph.22.195

Source DB:  PubMed          Journal:  J Prev Med Public Health        ISSN: 1975-8375


  16 in total

Review 1.  Cost-of-illness studies : a review of current methods.

Authors:  Ebere Akobundu; Jing Ju; Lisa Blatt; C Daniel Mullins
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

2.  A normative perspective on discounting health outcomes.

Authors:  Adam Oliver
Journal:  J Health Serv Res Policy       Date:  2013-06-04

3.  South Korean time trade-off values for EQ-5D health states: modeling with observed values for 101 health states.

Authors:  Yeon-Kyeng Lee; Hae-Sung Nam; Ling-Hsiang Chuang; Keon-Yeop Kim; Hae-Kyung Yang; In-Sun Kwon; Paul Kind; Sun-Seog Kweon; Young-Tack Kim
Journal:  Value Health       Date:  2009-07-29       Impact factor: 5.725

4.  Model parameter estimation and uncertainty analysis: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group-6.

Authors:  Andrew H Briggs; Milton C Weinstein; Elisabeth A L Fenwick; Jonathan Karnon; Mark J Sculpher; A David Paltiel
Journal:  Med Decis Making       Date:  2012 Sep-Oct       Impact factor: 2.583

5.  Discounting the Recommendations of the Second Panel on Cost-Effectiveness in Health and Medicine.

Authors:  Mike Paulden; James F O'Mahony; Christopher McCabe
Journal:  Pharmacoeconomics       Date:  2017-01       Impact factor: 4.981

6.  Evaluation of willingness to pay per quality-adjusted life year for a cure: A contingent valuation method using a scenario-based survey.

Authors:  Hyun Jin Song; Eui-Kyung Lee
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

Review 7.  Modelling the epidemiology of infectious diseases for decision analysis: a primer.

Authors:  Mark Jit; Marc Brisson
Journal:  Pharmacoeconomics       Date:  2011-05       Impact factor: 4.981

Review 8.  A Review of the Types and Characteristics of Healthy Life Expectancy and Methodological Issues.

Authors:  Young-Eun Kim; Yoon-Sun Jung; Minsu Ock; Seok-Jun Yoon
Journal:  J Prev Med Public Health       Date:  2022-01-16

9.  Cost comparison between surgical treatments and endoscopic submucosal dissection in patients with early gastric cancer in Korea.

Authors:  Younhee Kim; Young Woo Kim; Il Ju Choi; Joo Young Cho; Jong Hee Kim; Jin Won Kwon; Ja Youn Lee; Na Rae Lee; Sang Yong Seol
Journal:  Gut Liver       Date:  2015-03       Impact factor: 4.519

10.  Improving Patient Access to New Drugs in South Korea: Evaluation of the National Drug Formulary System.

Authors:  Seung-Lai Yoo; Dae-Jung Kim; Seung-Mi Lee; Won-Gu Kang; Sang-Yoon Kim; Jong Hyuk Lee; Dong-Churl Suh
Journal:  Int J Environ Res Public Health       Date:  2019-01-21       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.